Andere Sprachen Lipum AB

Aktien

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 18:00:00 26.06.2024			% 5 Tage	% 1. Jan.
8.65 ^SEK	+0.58%		+0.58%	+32.67%

18.06.	Lipum AB (publ) schließt Teil der klinischen Phase-I-Studie mit Mehrfachdosierung ab	CI
28.05.	Lipum AB (publ) meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

BioStock: Lipum's CEO comments on multiple-dose results in phase I	20.06.
LIPUM REPORTS FURTHER PROGRESS WHERE THE MULTIPLE DOSE PART OF THE PHASE I CLINICAL STUDY IS COMPLETED	18.06.
Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study	18.06.
Lipum: A new approach to chronic inflammation	29.05.
Lipum Q1 - Initiating preparations for phase II	28.05.
Lipum AB – interim report Q1 for the period January-March 2024	28.05.
Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	28.05.
BioStock: Flerie Invest continues to support Lipum	13.05.
Lipum Obtains SEK20 Million Loan from Flerie Invest	06.05.
Lipum receives loan commitment of SEK 20 million	06.05.
BioStock: Lipum's CEO looks ahead after the rights issue	26.04.
Lipum announces final outcome of the rights issue	25.04.
Lipum - Financed and ready to go	24.04.
Lipum announces preliminary outcome of the rights issue	23.04.
Lipum and NorthX Biologics enter into new strategic manufacturing alliance	18.04.
Lipum has been granted funding from Swelife	12.04.
Lipum publishes supplement to the prospectus regarding the rights issue	05.04.
Lipum publishes prospectus regarding the rights issue	03.04.
BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment	03.04.
Lipum AB - Report from the Extraordinary General Meeting	02.04.

Keine Ergebnisse zu dieser Suche